Neurodivergent Cannabis Intelligence
A harm-reduction guide for adults whose cannabis response doesn't fit one-size-fits-all advice.
Start your Safety PassportCannabis affects neurodivergent people in complicated ways. Some autistic, ADHD, AuDHD, sensory-sensitive, trauma-affected, or chronically ill adults report that cannabinoids help with sleep, pain, appetite, sensory overload, GI distress, emotional regulation, or social ease. Others report anxiety, paranoia, fog, dependence, overstimulation, or worse function. Both realities matter.
CannaIQ does not claim cannabis treats autism, ADHD, anxiety, or mental health conditions. We take a third path: harm reduction, education, safety screening, medication awareness, product-category intelligence, and response tracking.
Your nervous system matters. Your medications matter. Your dose matters. Your route matters. Your tolerance matters. Your prior reactions matter. Before you choose a product, CannaIQ helps you understand what is known, what is uncertain, what risks apply to you, and what to track next.
This is not cannabis hype. This is cannabis intelligence.
What CannaIQ does
What CannaIQ does not do
Who this guide is for
This guide is for adults whose nervous systems are wired differently. If you've ever felt like generic cannabis advice didn't fit your experience — too sensitive to dosing, complicated by medications, complicated by trauma, or complicated by symptoms no dispensary asks about — this is where to start.
Cross-vertical evidence reviews
For trauma-affected populations including veterans and first responders, see our PTSD evidence review — which documents why the VA/DoD 2023 Clinical Practice Guideline recommends against cannabis for PTSD.
The evidence at a glance
Cannabinoids have established evidence for short-term chronic pain relief in adults.
National Academies 2017
Moderate evidence for short-term sleep improvements in chronic pain, MS, fibromyalgia.
National Academies 2017
Small studies show possible improvements in behavioral symptoms and social responsiveness. Adverse effects ranged in severity.
Pereira et al. 2025 — systematic review of 4 studies, 353 participants
No evidence cannabis is an effective treatment for ADHD.
CADDRA December 2024 position statement
Dose-response relationship. Adolescent exposure especially concerning. OR 3.90 for heaviest users versus non-users.
Marconi et al. 2016 meta-analysis
Six paths in
Every neurodivergent person enters cannabis intelligence differently. Pick where you actually are.
Legal, tested cannabis near you. Let me find what's worth your time without making you slog through 50 dispensary menus.
Start where you are. Low dose, calm pacing, real explanations. No judgment, no hype, no rabbit holes you did not ask for.
Most people aren't broken — they're overloaded. Let's slow it down. Bud will help you understand what your nervous system is asking for before we talk products.
Drop your meds — Bud will run them through 302,516 verified interactions. Real flags. Real next steps. No 'consult your doctor' brush-off.
ECS, terpenes, cannabinoids, CYP interactions, FAAH polymorphisms — explained in plain language. The depth scales to your curiosity.
Lab-verified products from sources that pass our safety and licensing checks. The verified path.
How CannaIQ works
Your nervous system, your goals, your meds, your history — all in one place that stays yours.
CannaIQ runs your medication profile against 302,516 verified interactions.
Psychosis history. Pregnancy. Sedative stacking. Stimulant interactions. Real flags, not generic warnings.
We tell you what's known and what isn't. Evidence tiers are explicit on every claim.
Categories that fit your profile — not strain hype, not best-seller lists.
Better / Same / Worse plus specific outcome domains. Your nervous system, measured by you.
Your data, your patterns, your insights. The longer you use CannaIQ, the better it knows what works for you.
If your profile or symptoms warrant it, Bud will tell you. Some questions need a pharmacist or a physician.
Cannabis response varies widely among neurodivergent adults. CannaIQ provides a harm-reduction framework — not a treatment claim.
CannaIQ does not claim cannabis treats autism, ADHD, anxiety, or any neurodivergent condition. We help users understand their response patterns and safety risks.
Safety flags
Medication flags
Route caution
Edibles have longer duration and higher overdose risk. Inhalation routes have faster feedback but lung exposure concerns.
What to track
Start with a Safety Passport intake to track sensory state, sleep, medications, and outcomes over time.
When to escalate
If you experience aggression, paranoia, dissociation, or worsening symptoms, pause and consult a clinician or pharmacist.
Sources
Free. Private. Bud-guided. Built for real life.
Start your Safety Passport